The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression
Open accessAbstract
The hormone glucose-dependent insulinotropic polypeptide (GIP) potently stimulates insulin secretion and promotes beta-cell proliferation and cell survival. In the present study we identified Forkhead (Foxo1)-mediated suppression of the bax gene as a critical component of the effects of GIP on cell survival. Treatment of INS-1(832/13) beta-cells with GIP resulted in concentration-dependent activation of the phosphatidylinositol 3-kinase (PI3K)/protein kinase B (PKB)/Foxo1 signaling module. In parallel studies, GIP decreased bax promoter activity. Serial deletion analysis of the bax promoter demonstrated that the region -682 to -320, containing FHRE-II (5AAAACAAACA), was responsible for GIP-mediated effects. Foxo1 bound to FHRE-II in gel mobility shift assays, and Foxo1-FHRE-II interactions conferred GIP responsiveness to the bax promoter. INS-1 cells incubated under proapoptotic and glucolipotoxic conditions demonstrated increased nuclear localization of Foxo1 and bax promoter activity and decreased cytoplasmic phospho-PKB/Foxo1. GIP partially restored expression PKB/Foxo1 and bax promoter activity. Similar protective effects were found with dispersed islet cells from C57BL/6 mice, but not with those from GIP receptor knock-out (GIPR(-/-)) mice. GIP treatment reduced glucolipotoxicity-induced cell death in C57 BL/6 and Bax(-/-) islets, but not GIPR(-/-) mouse islets. Chronic treatment of Vancouver diabetic fatty Zucker rats with GIP resulted in down-regulation of Bax and up-regulation of Bcl-2 in pancreatic beta-cells. The results show that PI3K/PKB/Foxo1 signaling mediates GIP suppression of bax gene expression and that this module is a key pathway by which GIP regulates beta-cell apoptosis in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death
Oltval, Z. N., Milliman, C. L., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)90509-o · Cited by 6,003
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502
Miyawaki, K., Yamada, Y., Yano, H., Niwa, H., Ban, N., Ihara, Y., Kubota, A., Fujimoto, S., Kajikawa, M., Kuroe, A., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14843 · Cited by 454
Research works printed but not linked: 36
- Brunet, 2001, Curr. Opin. Neurobiol., 11, 297, 10.1016/S0959-4388(00)00211-7 · DOI · Paper page
- Franke, 1997, Cell, 88, 435, 10.1016/S0092-8674(00)81883-8 · DOI · Paper page
- Cardone, 1998, Science, 282, 1318, 10.1126/science.282.5392.1318 · DOI · Paper page
- Datta, 1997, Cell, 91, 231, 10.1016/S0092-8674(00)80405-5 · DOI · Paper page
- Pap, 1998, J. Biol. Chem., 273, 19929, 10.1074/jbc.273.32.19929 · DOI · Paper page
- Brunet, 1999, Cell, 96, 857, 10.1016/S0092-8674(00)80595-4 · DOI · Paper page
- Kaestner, 2000, Genes Dev., 14, 142, 10.1101/gad.14.2.142 · DOI · Paper page
- Arden, 2002, Arch. Biochem. Biophys., 403, 292, 10.1016/S0003-9861(02)00207-2 · DOI
- Rena, 2002, EMBO J., 21, 2263, 10.1093/emboj/21.9.2263 · DOI · Paper page
- Kops, 2002, Mol. Cell. Biol., 22, 2025, 10.1128/MCB.22.7.2025-2036.2002 · DOI · Paper page
- Nemoto, 2002, Science, 295, 2450, 10.1126/science.1069004 · DOI · Paper page
- Tran, 2002, Science, 296, 530, 10.1126/science.1068712 · DOI · Paper page
- Webster, 2004, Circ. Res., 94, 856, 10.1161/01.RES.0000126699.49835.5D · DOI
- Kieffer, 1999, Endocr. Rev., 20, 876, 10.1210/edrv.20.6.0385 · DOI · Paper page
- Drucker, 2003, Mol. Endocrinol., 17, 161, 10.1210/me.2002-0306 · DOI · Paper page
- Trümper, 2002, J. Endocrinol., 174, 233, 10.1677/joe.0.1740233 · DOI · Paper page
- Ehses, 2003, Endocrinology, 144, 4433, 10.1210/en.2002-0068 · DOI · Paper page
- Trümper, 2001, Mol. Endocrinol., 15, 1559
- Knudsen, 1995, Science, 270, 96, 10.1126/science.270.5233.96 · DOI · Paper page
- MacDonald, 2001, Mol. Endocrinol., 15, 1423, 10.1210/mend.15.8.0685 · doi:10.1210/mend.15.8.0685 · Paper page
- Alessi, 1996, EMBO J., 5, 6541, 10.1002/j.1460-2075.1996.tb01045.x · DOI · Paper page
- Prentki, 2002, Diabetes, 51, S405, 10.2337/diabetes.51.2007.S405 · DOI · Paper page
- Winter, 2004, Diabetes, 53, A447
- Nakae, 2002, Nat. Gen., 32, 245, 10.1038/ng890 · DOI · Paper page
- Kitamura, 2002, J. Clin. Investig., 110, 1839, 10.1172/JCI200216857 · DOI
- Accili, 2004, Diabetes, 53, 1633, 10.2337/diabetes.53.7.1633 · DOI · Paper page
- Yamauchi, 2001, J. Biol. Chem., 276, 23362, 10.1074/jbc.M011752200 · DOI
- Cheung, 2004, J. Biol. Chem., 279, 45308, 10.1074/jbc.C400333200 · DOI
- Uhlik, 2003, Nat. Cell Biol., 5, 1104, 10.1038/ncb1071 · DOI · Paper page
- Kilic, 2002, Cell Death Differ., 9, 125, 10.1038/sj.cdd.4400968 · DOI
- Schamberger, 2005, Exp. Cell Res., 302, 115, 10.1016/j.yexcr.2004.08.026 · doi:10.1016/j.yexcr.2004.08.026
- Unger, 2001, Diabetes, 50, S118, 10.2337/diabetes.50.2007.S118 · DOI · Paper page
- Kharroubi, 2004, Endocrinology, 145, 5087, 10.1210/en.2004-0478 · DOI · Paper page
- Maestre, 2003, Endocrinology, 144, 335, 10.1210/en.2001-211282 · DOI · Paper page
- Hui, 2004, J. Cell. Physiol., 200, 177, 10.1002/jcp.20021 · DOI
- Adams, 1998, Science, 281, 1322, 10.1126/science.281.5381.1322 · DOI · Paper page
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The biology of incretin hormones
Drucker, D. J. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.004 · Cited by 2,210
Pancreatic regulation of glucose homeostasis.
Röder, P. V., Wu, B., Liu, Y., & Han, W. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.6 · Cited by 985
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
“223,224 GLP-1 also inhibits glucagon release from α -cells, which is bene fi cial for reducing blood glucose levels since glucagon promotes hepatic gluconeogenesis.”
BackgroundThe role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
Metadata
- Authors
- Kim, S.-J., Winter, K., Nian, C., Tsuneoka, M., Koda, Y., & McIntosh, C. H. S.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-06
- Volume
- 280
- Issue
- 23
- Pages
- 22297-22307
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2074519205
- Cited by
- 241
- References
- 4
- FWCI
- 12.35
- Type
- journal article
- Language
- en
- Open access
- hybrid
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5616 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression. https://app.cochat.ai/papers/10.1074/jbc.m500540200
- The paper
- Kim, S.-J., Winter, K., Nian, C., Tsuneoka, M., Koda, Y., & McIntosh, C. H. S. (2005). Glucose-dependent Insulinotropic Polypeptide (GIP) Stimulation of Pancreatic β-Cell Survival Is Dependent upon Phosphatidylinositol 3-Kinase (PI3K)/Protein Kinase B (PKB) Signaling, Inactivation of the Forkhead Transcription Factor Foxo1, and Down-regulation of bax Expression. Journal of Biological Chemistry. https://doi.org/10.1074/jbc.m500540200
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.